Patents
Patents for C07C 205 - Compounds containing nitro groups bound to a carbon skeleton (11,422)
05/2004
05/19/2004CN1496975A Emodin derivative with anti-tumour activity
05/19/2004CN1150159C Intermediate for preparing allyl quinone derivative and prep. of the same
05/18/2004US6737554 Naphthalene and/ or 1-nitronaphthalene is reacted with nitric acid in the presence of a zeolite.
05/18/2004US6737548 Process for preparing 1,5-diaminonaphthalene derivative
05/18/2004US6737525 Electrophilic fluorination
05/13/2004US20040092770 Alpha-haloenamine reagents
05/13/2004US20040092728 Using halodimethylsulfonium halide as activated nucleophilic agent
05/13/2004US20040092595 Analgesic agent
05/12/2004EP1417197A1 Fungicidal 1-benzoxepin derivatives
05/12/2004EP1015441B1 Process to produce 4-hydroxy-2-oxo-pyrane derivatives useful as protease inhibitors
05/12/2004CN1495158A Intermediate for preparing isoxazolinyl-3-acylbenzene and process for preparing said intermediate
05/12/2004CN1495153A 2-methoxy diphenyl ketone compound intermediate and its preparation method
05/12/2004CN1149193C Substituted tricyclic compound
05/11/2004US6733883 Fluorinated dendrons and self-organizing ultrahigh density nanocylinder compositions
05/06/2004WO2004037765A1 A process for the preparation of 3,4,5-trifluoronitrobenzene
05/06/2004US20040087798 Novel amide compounds
05/06/2004US20040087590 Novel biphenyl and biphenyl-like cannabinoids
05/06/2004EP1415995A2 Photocleavable agents and conjugates for the detection and isolation of biomolecules
05/06/2004EP1414781A1 Method for the continuous production of 2-bromo-2-nitro-1, 3-propanediol
05/06/2004EP1140826B1 Method for producing (2s,4r,9s)-octahydro-1h-indole-2-carboxylic acid and intermediate products therefor
04/2004
04/29/2004WO2004035520A1 Process for production of an acetylenic compound
04/29/2004WO2003009807A3 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
04/29/2004US20040082805 Cytokine antagonist; immunology, viricides, antitumor agents, anticancer agents
04/29/2004US20040082647 Anticholesterol agents; controlling bile acid transfer into intestines
04/28/2004EP1413572A1 Process for producing acid anhydride
04/28/2004EP1412447A2 Novel mesogens and methods for their synthesis and use
04/28/2004EP1412311A1 Novel treatment of adrenocortical hypersecretion and tumour growth
04/28/2004CN1492851A Method for synthesizing camptothecin-relating compounds
04/28/2004CN1147456C Fungus-killing compound of 2-methoxydiphenylketones
04/27/2004US6727393 Of quaternary salt deprotonated hydroxy aromatic acid; reactive extraction in hydroxide; circulation
04/22/2004WO2004013077A3 Cyclopentanone and cyclopentanone derivatives as potent activators of hsf-1
04/22/2004US20040077872 Palladium salt without a ligand being used as palladium catalyst; cheap, simple and commercially attractive process involving an optionally substituted aromatic bromide
04/22/2004US20040077553 Such as 1-(((alpha-propanoyloxybutoxy)carbonyl)aminomethyl)-1-cyclohexane acetic acid; ability to cross blood brain barrier; sustained release
04/22/2004US20040074017 Protecting reduction- sensitive dyes in the course of dyeing or printing fiber materials with dyes using a compound of the formula (I) or a mixture thereof where the substituents are each as defined in the claims; novel compounds of the formula
04/21/2004EP1409446A1 Method for the nitration of phenolic compounds
04/21/2004EP1409131A2 Palladium-catalysed carbon-carbon bond forming reactions in compressed carbon dioxide
04/21/2004EP1409125A1 Microencapsulated catalyst, methods of preparation and methods of use thereof
04/21/2004EP1409122A2 Catalytic compositions and methods for asymmetric aldol reactions
04/21/2004EP1408963A1 2- 5-(5-CARBAMIMIDOYL-1 i H /i -HETEROARYL)-6-HYDROXYBIPHENYL-3-YL]-SUCCINIC ACID DERIVATIVES AS FACTOR VIIA INHIBITORS
04/21/2004EP1202949B1 Process for the preparation of acylated 1,3-dicarbonyl compounds
04/21/2004EP1171406B1 Method of producing biaryls
04/21/2004EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
04/21/2004CN1490301A Disproportionation of nitro aromatic compounds
04/15/2004WO2004031124A1 Cyclic nitromethyl acetic acid derivatives
04/15/2004WO2003083063A3 Common ligand mimics: naphtoates
04/15/2004US20040072673 Sol-gel derived porous microcomposite of perfluorinated ion-exchange polymer and metal oxide
04/15/2004US20040072672 Perfluorinated ion-exchange polymers (pfiep) containing pendant sulfonic acid groups and/or pendant carboxylic acid groups entrapped within and highly dispersed throughout a metal oxide network; high surface area
04/15/2004US20040072671 Sol-gel derived porous microcomposite of perfluorinated ion-exchange polymer and metal oxide
04/15/2004US20040071187 Compound having at least two aromatic rings substituted with at least one carboxy group
04/15/2004CA2498186A1 Cyclic nitromethyl acetic acid derivatives
04/14/2004EP1375465A9 Cyclooctanone derivative and cyclodecanone derivative, and use thereof
04/14/2004CN1488621A Method for synthesizing trimethylphenyl musk using C9 mixed aromatics as raw material
04/13/2004US6720039 Also having charge transport capability; optical sensors, electroluminescence devices, photoconductors, space light modulating devices, thin film transistors, image display devices
04/08/2004US20040068146 Sol-gel derived porous microcomposite of perfluorinated ion-exchange polymer and metal oxide
04/07/2004EP1404324A2 Prodrugs of gaba analogs, compositions and uses thereof
04/07/2004EP1404310A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity
04/07/2004CN1487919A New mandelic acid derivatives and their use as throbin inhibitors
04/01/2004WO2004027078A2 Fluorinated dendrons and self-organizing ultrahigh density nanocylinder compositions
04/01/2004WO2004026808A1 Manufacturing process for no-donating compounds such as no-donating diclofenac
04/01/2004WO2003088927A3 Novel curcumin analogues and uses thereof
04/01/2004US20040063781 Compounds active at the glucocorticoid receptor II
04/01/2004US20040062941 Mixture of porous polymer and solid phase support; fine particle sizes; anchoring organic compounds
04/01/2004US20040062927 Fluorinated dendrons and self-organizing ultrahigh density nanocylinder compositions
04/01/2004CA2498943A1 Manufacturing process for no-donating compounds such as no-donating diclofenac
03/2004
03/31/2004EP1403238A1 Process for producing fluorinated alcohol
03/31/2004EP1401844A2 Use of a composition of an ionic nature as a substrate reagent, a composition constituting a fluorination reagent and a method using same
03/30/2004CA2194502C 2-[1',2',4'-triazol-3'-yloxymethylene]anilides, their preparation and their use
03/25/2004WO2003060852A3 Catalytic osmium-assisted oxidative cleavage of olefins
03/25/2004US20040059137 Method for producing compounds having a cf2o bridge
03/24/2004EP1399412A1 Photolabile esters and their uses
03/24/2004CN1483727A Halogenationg agent
03/24/2004CN1483719A Wethod for preparation acetylacetic ester
03/18/2004WO2003055446A9 Antifungal phenethylene
03/18/2004WO2002079339A3 Metal catalyzed reactions
03/18/2004US20040054216 Method for producing lysine derivative
03/18/2004US20040054196 Method for producing cyclic carboxylic orthoester fluorides and corresponding compounds
03/18/2004US20040053890 Naphthalene derivatives
03/18/2004US20040053217 Using conjugate agents comprise of photoreactive moiety to identify preferential micro and/or macromolecules in heterologous mixtures
03/17/2004CN1483017A Process for the production of 1, 5-naphthalenediamine
03/16/2004US6706924 Process for the production of 1,5-naphthalenediamine
03/16/2004US6706338 Liquid-crystalline compounds
03/16/2004CA2139348C Improved chemiluminescent 1,2-dioxetanes
03/11/2004US20040049065 Substituted 3-phenoxy-1-phenyl acetylene derivatives), herbicides
03/11/2004US20040046150 Liquid-crystalline media comprising at least compound of the formula I and to electro-optical displays containing a liquid-crystalline medium of this type.
03/09/2004US6703532 Process for the nitration of xylene isomers using zeolite beta catalyst
03/04/2004WO2004017920A2 Novel biphenyl and biphenyl-like cannabinoids
03/04/2004US20040044059 Tubulin binding ligands and corresponding prodrug constructs
03/04/2004US20040044049 Compounds for inhibiting insulin secretion and methods related thereto
03/04/2004US20040043993 Premenstrual tension; anticancer agents; osteoporosis; hormone replacement therapy
03/04/2004US20040043969 Tubulin binding agents and corresponding prodrug constructs
03/04/2004CA2495903A1 Novel biphenyl and biphenyl-like cannabinoids
03/03/2004EP1394140A1 Enantioselektive Reformatsky-Process for the preparation of optically active alcohols, amines and their derivatives
03/03/2004EP1392673A2 1,3-dihydroxybenzene derivatives and colorants containing said compounds
03/03/2004EP1392603A2 Processes for the purification of higher diamondoids and compositions comprising such diamondoids
03/03/2004EP1274672B1 Method for producing substituted nitro benzoic acids by oxidation of corresponding nitro toluenes, nitro benzyl alcohols, esters and/or ethers
03/03/2004CN1479703A Method for producing compounds having CF2O bridge
02/2004
02/26/2004WO2004016348A1 Tethered catalyst processes in microchannel reactors and systems containing a tethered catalyst or tethered chiral auxiliary
02/26/2004US20040039227 Method for producing substituted nitro benzoic acids by oxidation of corresponding nitro toluenes, nitrol benzyl alcohols, esters and/or ethers
02/26/2004DE10333080A1 Production of acetoacetate esters for use as pharmaceutical intermediates, e.g. p-nitrobenzyl acetoacetate, involves reacting diketene with a benzyl alcohol in presence of a cyclic amine as catalyst
02/25/2004EP1390343A1 Novel retinoid derivatives and methods for producing said compounds and an anti-cancer pharmaceutical composition comprising said compounds
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 115